Manufacturing Process Development for Belzutifan, Part 4: Nitrogen Flow Criticality for Transfer Hydrogenation Control

Manufacturing Process Development for Belzutifan, Part 5: A Streamlined Fluorination–Dynamic Kinetic Resolution Process

(2021) Tao Wang et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

Manufacturing Process Development for Belzutifan, Part 3: Completing a Streamlined Through-Process with a Safe and Scalable Oxidation

(2021) Zhiwei Chen et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

Manufacturing Process Development for Belzutifan, Part 2: A Continuous Flow Visible-Light-Induced Benzylic Bromination

(2021) Cecilia Bottecchia et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

Manufacturing Process Development for Belzutifan, Part 1: A Concise Synthesis of the Indanone Starting Material

(2021) Feng Peng et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

Manufacturing Process Development for Belzutifan, Part 6: Ensuring Scalability for a Deoxyfluorination Reaction

(2021) Michael Pirnot et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

Targeting the HIF2–VEGF axis in renal cell carcinoma

(2020) Toni K. Choueiri et al.   NATURE MEDICINE

An open-label phase II study to evaluate PT2977 for the treatment of von Hippel-Lindau disease-associated renal cell carcinoma.

(2019) Eric Jonasch et al.   JOURNAL OF CLINICAL ONCOLOGY

3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma

(2019) Rui Xu et al.   JOURNAL OF MEDICINAL CHEMISTRY

Allosteric inhibition of HIF-2α as a novel therapy for clear cell renal cell carcinoma

(2019) Yancheng Yu et al.   DRUG DISCOVERY TODAY

Hazardous properties of hydrogen and hydrogen containing fuel gases

(2019) Maria Molnarne et al.   PROCESS SAFETY AND ENVIRONMENTAL PROTECTION

The role of hypoxia-inducible factor-2 alpha in angiogenesis

(2018) Christina Befani et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Hypoxia-Inducible Factor 2-Dependent Pathways Driving Von Hippel–Lindau-Deficient Renal Cancer

(2018) Florinda Meléndez-Rodríguez et al.   Frontiers in Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Systemic Therapy for Metastatic Renal-Cell Carcinoma

(2017) Toni K. Choueiri et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renal cell carcinoma

(2017) James J. Hsieh et al.   Nature Reviews Disease Primers

Improved Process for Preparation of tert-Butanesulfinyl Ketimines of Hindered Ketones under Nitrogen Flow

(2016) Samuel Tabet et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

The VHL/HIF axis in clear cell renal carcinoma

(2012) Chuan Shen et al.   SEMINARS IN CANCER BIOLOGY

Reaction Development and Mechanistic Study of a Ruthenium Catalyzed Intramolecular Asymmetric Reductive Amination en Route to the Dual Orexin Inhibitor Suvorexant (MK-4305)

(2011) Neil A. Strotman et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Using the Right Green Yardstick: Why Process Mass Intensity Is Used in the Pharmaceutical Industry To Drive More Sustainable Processes

(2011) Concepcion Jimenez-Gonzalez et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT

NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist

(2010) Gregory R. Fulmer et al.   ORGANOMETALLICS

Scalable Reactor Design for Pharmaceuticals and Fine Chemicals Production. 3. A Novel Gas−Liquid Reactor for Catalytic Asymmetric Transfer Hydrogenation with Simultaneous Acetone Stripping

(2008) Xiuyan Sun et al.   ORGANIC PROCESS RESEARCH & DEVELOPMENT